Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease
Sangamo Therapeutics, a genomic medicine company, today announced updated preliminary data as of the October […]
AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and […]
Xspray Pharma Partners with EVERSANA for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)
Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of […]
Dawn Health partners with leading Pharmaceutical Company, Novartis, to Transform Chronic Care
Dawn Health, a global leader in digital health, has announced a strategic partnership with Novartis, […]
ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva is as effective as daily oral Biktarvy for the treatment of HIV-1
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi […]
Lineage Enters Into Option and License Agreement With Eterna Therapeutics to Develop Hypoimmune Pluripotent Cell Lines for Multiple Neurology Indications
Lineage Cell Therapeutics, a clinical-stage biotechnology company developing allogeneic cell therapies to replace and restore […]
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
Shabbir Mostafa, Recipharm, on Medical Devices
In this video, Shabbir Mostafa, the Head of Business Development at Recipharm, discusses Recipharm’s focus […]
CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development
CLEARA Biotech, a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more